Filing Details
- Accession Number:
- 0001140361-22-011256
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-03-25 17:40:13
- Reporting Period:
- 2022-03-23
- Accepted Time:
- 2022-03-25 17:40:13
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1104506 | Insmed Inc | INSM | Pharmaceutical Preparations (2834) | 541972729 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1402051 | William Lewis | 700 Us Highway 202/206 Bridgewater NJ 08807 | Chair And Ceo | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-03-23 | 30,228 | $14.24 | 247,852 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-03-23 | 30,228 | $23.16 | 217,624 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2022-03-23 | 65,405 | $16.16 | 283,029 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-03-23 | 65,405 | $23.16 | 217,624 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2022-03-23 | 981 | $16.16 | 218,605 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-03-23 | 981 | $23.61 | 217,624 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2022-03-23 | 30,228 | $0.00 | 30,228 | $14.24 |
| Common Stock | Stock Option (right to buy) | Disposition | 2022-03-23 | 65,405 | $0.00 | 65,405 | $16.16 |
| Common Stock | Stock Option (right to buy) | Disposition | 2022-03-23 | 981 | $0.00 | 981 | $16.16 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2023-10-31 | No | 4 | M | Direct | |
| 97,595 | 2026-01-07 | No | 4 | M | Direct | |
| 96,614 | 2026-01-07 | No | 4 | M | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
- This is the weighted average sales price representing 30,228 shares sold at prices ranging from $22.62 to $23.61 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
- This is the weighted average sales price representing 65,405 shares sold at prices ranging from $22.61 to $23.60 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
- This is the weighted average sales price representing 981 shares sold at prices ranging from $23.61 to $23.64 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
- The options became exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.
Billionaire Hedge Funds
